image
Healthcare - Biotechnology - NASDAQ - US
$ 21.47
-2.36 %
$ 1.05 B
Market Cap
-11.36
P/E
ELVN - NET CHANGE IN CASH

Net Change in Cash ELVN - Enliven Therapeutics, Inc.

image
24.6 M
LAST VALUE
79.15%
2 YEAR CAGR
66.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR